- Home
- FT vs ARAY Comparison
FT vs ARAY Comparison
Compare FT & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FT
- ARAY
- Stock Information
- Founded
- FT 1988
- ARAY 1990
- Country
- FT United States
- ARAY United States
- Employees
- FT N/A
- ARAY N/A
- Industry
- FT Trusts Except Educational Religious and Charitable
- ARAY Medical/Dental Instruments
- Sector
- FT Finance
- ARAY Health Care
- Exchange
- FT Nasdaq
- ARAY Nasdaq
- Market Cap
- FT 185.7M
- ARAY 180.0M
- IPO Year
- FT N/A
- ARAY 2007
- Fundamental
- Price
- FT $7.52
- ARAY $2.28
- Analyst Decision
- FT
- ARAY Strong Buy
- Analyst Count
- FT 0
- ARAY 1
- Target Price
- FT N/A
- ARAY $9.00
- AVG Volume (30 Days)
- FT 63.0K
- ARAY 684.8K
- Earning Date
- FT 01-01-0001
- ARAY 02-05-2025
- Dividend Yield
- FT 7.85%
- ARAY N/A
- EPS Growth
- FT N/A
- ARAY N/A
- EPS
- FT N/A
- ARAY N/A
- Revenue
- FT N/A
- ARAY $444,204,000.00
- Revenue This Year
- FT N/A
- ARAY $6.64
- Revenue Next Year
- FT N/A
- ARAY $5.69
- P/E Ratio
- FT N/A
- ARAY N/A
- Revenue Growth
- FT N/A
- ARAY N/A
- 52 Week Low
- FT $5.97
- ARAY $1.40
- 52 Week High
- FT $7.23
- ARAY $2.95
- Technical
- Relative Strength Index (RSI)
- FT 57.22
- ARAY 61.63
- Support Level
- FT $7.45
- ARAY $2.18
- Resistance Level
- FT $7.65
- ARAY $2.34
- Average True Range (ATR)
- FT 0.09
- ARAY 0.13
- MACD
- FT 0.03
- ARAY 0.01
- Stochastic Oscillator
- FT 71.74
- ARAY 85.00
About FT Franklin Universal Trust
Franklin Universal Trust is a closed-end management investment company. Its primary investment objective is to provide high, current income consistent with the preservation of capital. Its secondary objective is the growth of income through dividend increases and capital appreciation. The fund invests in two asset classes being the high yield bonds and utility stocks.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.